Ocata Therapeutics Inc fka OCAT

[ddlas]

ddls--I'm not sure you understand the type of company ACTC is--most companies like them are high risk,high reward and any revenue they procure will be minimal until trials are over and they have a salable product on the market which can be years from now especially if the trials are held up for any reason.Meanwhile outside funding and/or dilution will be necessary.If you are waiting for meaningful revenue then avoid a stock like ACTC.